Total submissions: 1
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Labcorp Genetics |
RCV000550259 | SCV000644263 | pathogenic | Tuberous sclerosis 2 | 2017-03-23 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. While this particular variant has not been reported in the literature, loss-of-function variants in TSC2 are known to be pathogenic (PMID: 10205261, 17304050). This sequence change inserts 1 nucleotide in exon 16 of the TSC2 mRNA (c.1609dupC), causing a frameshift at codon 537. This creates a premature translational stop signal (p.Arg537Profs*52) and is expected to result in an absent or disrupted protein product. |